|Bid||9.44 x 1800|
|Ask||9.45 x 2900|
|Day's Range||9.33 - 9.58|
|52 Week Range||8.42 - 12.40|
|Beta (5Y Monthly)||1.19|
|PE Ratio (TTM)||5.47|
|Earnings Date||May 08, 2023 - May 12, 2023|
|Forward Dividend & Yield||0.48 (5.22%)|
|Ex-Dividend Date||Mar 08, 2023|
|1y Target Est||15.63|
Subscribe to Yahoo Finance Plus to view Fair Value for VTRS
Healthcare spinoffs aren't normally seen as companies with strong growth potential. More likely than not, spinoffs stem from a division of a company that, while possibly profitable, is seeing slower growth. Embecta (NASDAQ: EMBC.V), Viatris (NASDAQ: VTRS) and GE Healthcare Technologies (NASDAQ: GEHC) are three of the bigger healthcare spinoffs in recent years.
How high of a dividend yield does a stock need to have to be considered a high-yield stock? Opinions vary. However, many investors would include any stock with a yield that's greater than that offered by 10-year U.
Over the past year, Pfizer (NYSE: PFE) made a series of acquisitions, even announcing at one point that it planned to remain "very active in deal-making." On March 13, Pfizer announced the planned blockbuster acquisition of cancer specialist Seagen (NASDAQ: SGEN) for a massive $43 billion in cash. This move, expected to close by year-end or early 2024, will likely improve Pfizer's prospects, and it is only the latest in a series of important and successful strategic decisions the company's management has made.